| Title : A model-informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong-acting dipeptidyl peptidase-4 inhibitor - Cui_2023_Diabetes.Obes.Metab_26_592 |
| Author(s) : Cui C , Cao F , Kong, II , Wu Q , Li F , Li H , Liu D |
| Ref : Diabetes Obes Metab , 26 :592 , 2023 |
| Abstract : |
| PubMedSearch : Cui_2023_Diabetes.Obes.Metab_26_592 |
| PubMedID: 37953687 |
| Title : A model-informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong-acting dipeptidyl peptidase-4 inhibitor - Cui_2023_Diabetes.Obes.Metab_26_592 |
| Author(s) : Cui C , Cao F , Kong, II , Wu Q , Li F , Li H , Liu D |
| Ref : Diabetes Obes Metab , 26 :592 , 2023 |
| Abstract : |
| PubMedSearch : Cui_2023_Diabetes.Obes.Metab_26_592 |
| PubMedID: 37953687 |
| Title : A model-informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong-acting dipeptidyl peptidase-4 inhibitor - Cui_2023_Diabetes.Obes.Metab_26_592 |
| Author(s) : Cui C , Cao F , Kong, II , Wu Q , Li F , Li H , Liu D |
| Ref : Diabetes Obes Metab , 26 :592 , 2023 |
| Abstract : |
| PubMedSearch : Cui_2023_Diabetes.Obes.Metab_26_592 |
| PubMedID: 37953687 |